Table 1. Patients' characteristics.
SUVmean | |||||||
Patient no. | Gender | Age(y) | Size of lymph node (major * minor axis) | 18F-AIF-NOTA-PRGD2 | 18F-FDG | Lesions undergo FNAB* | Malignant or benign# |
1 | F | 35 | 18*10 | 3.1 | 2.9 | - | + |
21*16 | 3.1 | 6.9 | + | + | |||
2 | F | 26 | 9*7 | 2.6 | 5.6 | + | + |
16*11 | 3.2 | 4.7 | + | - | |||
11*10 | 2.2 | 4.0 | + | + | |||
11*10 | 1.8 | 4.2 | + | + | |||
3 | M | 21 | 8*4 | 1.6 | 2.5 | + | - |
4 | F | 45 | 19*12 | 2.8 | 2.6 | + | + |
18*17 | 2.8 | 2.2 | + | + | |||
14*11 | 4.2 | 4.4 | - | + | |||
10*8 | 3.5 | 4.3 | + | + | |||
5 | M | 65 | 19*17 | 3.9 | 8.0 | + | + |
16*13 | 3.1 | 5.7 | + | + | |||
16*10 | 3.2 | 6.4 | + | + | |||
17*9 | 3.0 | 5.0 | - | + | |||
6 | F | 22 | 14*10 | 3.8 | 3.8 | + | - |
7 | F | 60 | 15*14 | 3.9 | 2.8 | + | + |
8 | M | 59 | 16*15 | 2.8 | 4.0 | + | + |
9 | M | 27 | 13*7 | 2.5 | 2.2 | + | - |
10 | F | 26 | 27*22 | 4.1 | 3.8 | + | + |
14*11 | 2.7 | 2.9 | + | + | |||
11 | M | 33 | 16*11 | 2.8 | 3.3 | + | + |
12 | M | 35 | 16*13 | 4.0 | 5.3 | + | + |
11*10 | 2.8 | 5.0 | - | + | |||
9*9 | 2.7 | 6.7 | + | + | |||
13 | M | 21 | 10*6 | 1.2 | 3.8 | - | + |
14 | F | 49 | 11*10 | 2.2 | 5.6 | + | + |
15 | M | 41 | 12*7 | 1.4 | 3.7 | - | + |
16 | M | 24 | 8*7 | 3.7 | 3.4 | + | + |
11*8 | 2.9 | 4.3 | - | + | |||
17 | F | 38 | 15*11 | 1.7 | 6.6 | - | + |
13*10 | 1.9 | 4.5 | - | + | |||
12*7 | 1.8 | 4.0 | - | + | |||
18 | F | 58 | 8*6 | 0.4 | 2.8 | - | + |
7*6 | 1.5 | 3.4 | - | + | |||
13*9 | 2.1 | 5.4 | - | + | |||
11*7 | 2.2 | 4.3 | - | + | |||
19 | F | 50 | 17*10 | 1.6 | 8.2 | + | + |
20 | F | 38 | 11*10 | 1.4 | 2.8 | + | + |
*:+:performed with FNAB;-:without performing FNAB.
#:+:malignant;-:benign.